REGEN-COV Trademark Information

Trademark by Regeneron Pharmaceuticals, Inc.

Pharmaceutical preparations for treatment or prevention of COVID-19, coronavirus disease, and respiratory diseases and disorders; antivirals for treatment or prevention of COVID-19, coronavirus disease, and respiratory diseases and disorders

Classification Information

Intent to Use Trademark - Applicant has not submitted proof of use in commerce the the USPTO.

Primary Class: Class Details:
Class (005)
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
First Use Anywhere:: Not provided
First Use In Commerce: Not provided
General Information
Word mark: REGEN-COV
Status/Status Date:
NOTICE OF ALLOWANCE - ISSUED
2/16/2021
Serial Number: 90284296
Filing Date: 10/28/2020
Registration Number: NOT AVAILABLE
Registration Date: NOT AVAILABLE
Goods and Services: Pharmaceutical preparations for treatment or prevention of COVID-19, coronavirus disease, and respiratory diseases and disorders; antivirals for treatment or prevention of COVID-19, coronavirus disease, and respiratory diseases and disorders
Mark Description: NOT AVAILABLE
Type Of Mark: TradeMark
Published For Opposition Date: 12/22/2020
Last Applicant/Owner:
Regeneron Pharmaceuticals, Inc.
Tarrytown, NY 10591
Mark Drawing Code: Standard Character Mark
Design Search:
(NO DATA)
Register Type: Principal
Disclaimer: (NOT AVAILABLE)
Correspondent:
OHLANDT, GREELEY, RUGGIERO & PERLE, LLP
ONE LANDMARK SQUARE
10TH FLOOR
STAMFORD, CT 06901
Current Status:
NOTICE OF ALLOWANCE - ISSUED
2/16/2021
Correspondent Search:
TERRENCE J. MCALLISTER is a correspondent of REGEN-COV trademark.
Current Overall Rating:
RatingRatingRatingRatingRating

(0 review)

As seen on